Why Pfizer says it pushed for transparency and diversity in vaccine development process

Nov 9, 2020
To build public trust, Pfizer shared details of their trials: who was tested, the race and ethnicity of participants, how they were monitored, how to measure success and funding sources.
A person walks by Pfizer headquarters on Nov. 9, 2020, in New York City. Transparency is key for a vaccine-skeptical public.
David Dee Delgado/Getty Images